Cannabis Science Inc (fka CBIS)

[Solar Man 777]

Colombian Research Involving Cannabiods For Cancer Patients & Pharmaceutical Products Heats Up - Company Announces Appointment of Well Known Medical Marijuana Scientific Advisor


CORAL SPRINGS, Florida, April 22, 2014 /PRNewswire via COMTEX/ -- CORAL SPRINGS, Florida, April 22, 2014 /PRNewswire/ --

Cannabis advancers making strides in product developments and research events: New Colombia Resources, Inc. NEWC +17.44% , Cannabis Science, Inc. CBIS -5.27% , Medical Marijuana, Inc. MJNA +2.33% , Easton Pharmaceuticals, Inc. EAPH +16.30% , Extreme Biodiesel, Inc. XTRM +11.11% and Next Generation Energy Corp. NGMC +9.69%

New Colombia Resources, Inc. (otcqb:NEWC) a U.S. company with coal and other resource assets in Colombia, is pleased to announce the appointment of Dr. Robert J. Melamede PhD, President of Cannabis Science, Inc. (otc pink:CBIS), as a scientific advisor to gain approval to legally research and market cannabis based pharmaceutical products in Colombia and other Latin American countries. The Company is discussing a collaborative effort with Cannabis Science, Inc. Dr. Melamede, retired Chairman of the Biology department of the University of Colorado at Colorado Springs, is a world renowned leader in Cannabis research with many years investigating the human body's endocannabinoid system and its reaction to cannabinoids. Dr. Melamede has made many presentations around the globe explaining the benefits of cannabinoids for cancer patients..

To read the full press release, please click here: http://www.fnmprofiles.com/profiles-newc.html

Dr. Melamede, retired Chairman of the Biology department of the University of Colorado at Colorado Springs, is a world renowned leader in Cannabis research with many years investigating the human body s endocannabinoid system and its reaction to cannabinoids. Dr. Melamede has made many presentations around the globe explaining the benefits of cannabinoids for cancer patients. New Colombia Resources will form a joint venture to include U.S. and Colombian investors, universities, and pharmaceutical partners. New Colombia will work closely with government agencies to allow them permission to conduct research of cannabis based formulations. They will hire a reputable law firm to handle government approvals, lobbying, and public relations. The joint venture will conduct studies in different regions of Colombia with high incidences of the specific illness for which treatment is being researched without regard to socio-economic status

Cannabis Science, Inc. (CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting recently announced plans to enter the State of Nevada where new law expands medical cannabis opportunities to research, grows, and dispensaries. As the Company has created a partnership in Michigan to advance state cannabis law and pursue state-wide initiatives in Michigan, Cannabis Science intends to bring its know how and resources to Nevada, the state of Cannabis Science's Incorporation. The new law marks another milestone in the progression in the legalization process of the medical cannabis industry in the United States -- one that is aimed at ways of managing multiple ailments for patients. In addition, the new law is expected to contribute to the creation of new sources of revenue and employment opportunities within the state. Cannabis Science is well positioned to bring novel patient-based initiatives to Nevada.